Symbols

When will there be news on fda approval

7/8/2024 12:24am

Aime

The FDA approval news for Arcutis Biotherapeutics Inc. (ARQT) is expected on July 7, 2024, for the supplemental new drug application (sNDA) for roflumilast cream 0.15% for the treatment of atopic dermatitis (AD) in adults and children down to age 6¹. This is a significant regulatory catalyst for the company, and the decision is eagerly awaited by investors.

Source:

1. FDA Accepts Arcutis' Supplemental New Drug Application ...